INNO-LiPA HLA-DRB1 Amplification Plus - Taiwan Registration 168ade6dc73dfa1c3aed4e8f92aef558

Access comprehensive regulatory information for INNO-LiPA HLA-DRB1 Amplification Plus in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 168ade6dc73dfa1c3aed4e8f92aef558 and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.